Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry-Reference-Cited by-同舟云学术

Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

Published:2018-02 Issue: Volume:37 Page:154-160
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Müller Volkmar,Nabieva Naiba,Häberle Lothar,Taran Florin-Andrei,Hartkopf Andreas D.,Volz Bernhard,Overkamp Friedrich,Brandl Anna Lisa,Kolberg Hans-Christian,Hadji Peyman,Tesch Hans,Ettl Johannes,Lux Michael P.,Lüftner Diana,Belleville Erik,Fasching Peter A.,Janni Wolfgang,Beckmann Matthias W.,Wimberger Pauline,Hielscher Carsten,Fehm Tanja N.,Brucker Sara Y.,Wallwiener Diethelm,Schneeweiss Andreas,Wallwiener Markus

Funder

Novartis

Celgene

Pfizer

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference30 articles.

1. Trastuzumab emtansine for HER2-positive advanced breast cancer;Verma;N Engl J Med,2012

2. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer;Baselga;N Engl J Med,2012

3. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer;Baselga;N Engl J Med,2012